Â鶹ӳ»­

11:00 a.m.¨C5:15 p.m.
Room 156/158

Jobs Panel: Career Opportunities and Leadership Outside of the Clinic
Moderator: Rehema Thomas, M.D.

12:00¨C4:00 p.m.
Room 154

Panel: Shaping Your Path: Academic & Extracurricular Excellence in RadOnc
Panel Speaker: Stephanie Dudzinski, M.D., Ph.D.

3:45¨C5:00 p.m.
Room 301-304

Talk: Toxicity Reduction Efforts with Radiation Therapy
Presenter: 

8:00¨C8:30 a.m.
Room 20/21

Discussant: 

8:00¨C8:30 a.m.
Room 305/306/309

Discussant: 

11:00¨C3:00 p.m.
Room 154

Career Pathways Panelist: 

2:30¨C3:45 p.m.
Room 160

Discussant: 

4:45¨C6:00 p.m.
Room 20/21

Talk: Setting Up a Global Oncology Program: Identifying International Partners
Presenter: 

4:45¨C6:00 p.m.
Room 305/306/309

Moderator: 

4:45¨C6:00 p.m.
Room 314

Moderator: 

Abstract 161: Evaluating the Relationship of Baseline Skin Pigmentation Phenotype on the Evolution of Radiation Dermatitis
Presenter: 

4:45¨C6:00 p.m.
Room 160

Talk: Indications for Radiation Therapy in Leukemia: A Shifting Landscape
Presenter: 

4:45¨C6:00 p.m.
Room 153

Abstract 172: The Role of Adjuvant Primary Site Radiotherapy for Patients with Cutaneous Melanoma Microsatellitosis
Presenter: Kelsey Nordlund

Abstract 173: A Prospective Single-Arm Trial of Postoperative 36 Gy in 10 Fractions for Merkel Cell Carcinoma
Presenter: 

Abstract 175: Surgical Graft and Flap Toxicity Following Hypofractionated Adjuvant Radiotherapy for Primary Cutaneous Melanoma
Presenter: Noel Yang

8:00¨C9:00 a.m.
Room 20/21

Abstract 178: Crowdsourcing Tumor Auto-Contouring Solutions for MR-Guided Radiotherapy: The HNTS-MRG 2024 Challenge
Presenter: Kareem Wahid, Ph.D.

8:00¨C9:00 a.m.
Room 160

Moderator: Molly Tate, Ph.D.

10:45 a.m.¨C12:00 p.m.
Room 307/308

Moderator and Introduction: 

Talk: Target Volumes and Techniques for Definitive EBRT
Presenter: 

10:45 a.m.¨C12:00 p.m.
Room 152

Moderator: 

10:45 a.m.¨C12:00 p.m.
Room 22/23

Abstract 233: Early Prediction of Radiotherapy Outcome Using ADC Metrics for Head & Neck Squamous Cell Carcinoma
Presenter: Brigid McDonald, Ph.D.

Abstract 235: Unveiling Early Radiation Effects on the Hippocampus: ADC Dynamics Reveal Microstructural Changes during Therapy
Presenter: Ory Haisraely, M.D.

3:00¨C4:00 p.m.
ASTRO Communities Lounge

Speaker: 

3:00¨C4:00 p.m.
Room 156/158

Discussant: 

3:00¨C4:00 p.m.
Room 155/157

Abstract 255: Changes in High-Grade Glioma Target Volume and Prescription Dose Coverage between Postoperative MRI and MR-Simulation
Presenter: Sara Thower, Ph.D.

4:00¨C5:00
Booth 2137

5:00¨C6:00 p.m.
Room 160

Talk: Radiation Therapy for Grade 2-3 IDH-mutant Gliomas: Evidence, Innovation, and Evolving Practices
Presenter: 

5:00¨C6:00 p.m.
Room 156/158

Moderator: 

5:00¨C6:00 p.m.
Room 159

Moderator: 

5:00¨C6:00 p.m.
Room 301-304

Discussant: 

5:00¨C6:00 p.m.
Room 307/308

Moderator: 

5:00¨C6:00 p.m.
Room 155/157

Abstract 268: Ten-Year Outcomes of the Revised STARS Trial Comparing Radiation and Surgery for Early-Stage Non-Small Cell Lung Cancer
Presenter: Troy Kleber, M.D.

Discussant: 

5:00¨C6:00 p.m.
Room 20/21

Moderator, Questions and Answers: 

Talk: Addressing the Gaps: Rising Cancer Rates, Disparities, and Unique Needs in AYA Patients with Cancer
Presenter: Kelsey Corrigan, M.D.

8:00¨C9:00 a.m.
Room 156/158

Discussant: 

8:00¨C9:00 a.m.
Room 159

Moderator: 

12:45¨C2:00 p.m.
Room 310-312

Abstract 304: Genomic Mutation-Driven Stratification of Treatment Response to Stereotactic Spine Radiosurgery in Spinal Metastases
Presenter: Areeba Al-Sharfeen, M.D.

12:45¨C2:00 p.m.
Room 20/21

Abstract 1056: Vision-Language AI Model for Detecting PET/CT-Occult Lymph Node Metastasis in Early-Stage NSCLC Treated with SABR to Prevent Regional Recurrence
Presenter: Hui Xu, Ph.D.

12:45¨C2:00 p.m.
Room 155/157

Talk: Is There Still a Role for Radiotherapy in Extensive Stage SCLC?
Presenter: 

12:45¨C2:00 p.m.
Room 159

Talk: The Role of Radiotherapy in Modern Treatment of Endometrial Cancer - the Great Debate
Presenter: 

2:30¨C4:00 p.m.
Room 154

Case Discussions: 

2:30¨C4:30 p.m.
Room 153

The New NIH Review Criteria and Introductions
Moderator and Presenter: 

Specific Aims
Presenter: 

2:30¨C3:45 p.m.
Room 159

Introductions, Questions and Answers: 

4:00¨C5:00 p.m.
Room 155/157

Moderator: 

4:00¨C5:00 p.m.
Room 160

Talk: Surgical Considerations and Challenges for the Management of Patients with Retroperitoneal Sarcoma
Presenter: 

5:15¨C6:15 p.m.
Room 159

Talk: Informed Consent in the Context of Non-disclosure of Cancer Diagnosis
Presenter: 

8:00-9:00 a.m.
Room 154

Abstract 1113: Endoscopic Ultrasound Fine Needle Injection of NBTXR3 Activated by Radiotherapy with Concurrent Chemotherapy for Adenocarcinoma of the Esophagus: Feasibility and Safety of the Phase I Dose Escalation Part for the Photon-Based Cohort
Presenter: 

8:00-9:00 a.m.
Room 152

Abstract 355: Toward Advancement of Pediatric Cancer Treatment: A Comparative Study of Pediatric-Specific Models and Adult-Trained Commercial Tools for Radiotherapy Auto-Contouring
Presenter: Sogand Sadeghi, Ph.D.

8:00-9:00 a.m.
Room 160

Abstract 1129: Longitudinal Analysis of Log Files from Gated Delivery of Stereotactic Body Radiotherapy Using Motion Management in a 1.5 T MR-Linac
Presenter: Lucas McCullum

10:30-11:30 a.m.
Room 159

Abstrac 1143: Quantifying pan-cancer immune temperature to predict patient-specific radiation response and outcome
Presenter: Awino Maureiq Ojwang', Ph.D.

10:30-11:45 a.m.
Room 152

Abstract 365: Simultaneous T1, T2, T2*, and PDFF Estimation Using Magnetic Resonance Fingerprinting on a 1.5T MR-Linac for Head and Neck Cancer Patients
Presenter: Lucas McCullum

2:30¨C4:00 p.m.
Hall F

Abstract 2118: Outcomes for Patients with Localized Intrathoracic Soft Tissue Sarcomas Treated with Surgery and Radiation Therapy
Presenter: Tejaswi Kanala, M.D., M.B.B.S.

Abstract 2122: Impact of Abdominal Compression in MR-Guided Online Adaptive Planning for Abdominal Cancers Treated with a 1.5 Tesla MR-Linac
Presenter: Moghadaseh Khaleghibizaki

Abstract 2236: Automated Analysis of Log Files from Gated Delivery of Stereotactic Body Radiotherapy Using Motion Management in a 1.5 T MR-Linac: A Multi Institution Report
Presenter: 

4:45¨C6:00 p.m.
Hall F

Abstract 2331: Outcomes of Patients with Intracranial Germinoma Enrolled on the Pediatric Proton Photon Consortium Registry
Presenter: Elaine Cha, M.D.

Abstract 2375: Proton Therapy in Pediatric Craniopharyngioma: Comparison between Adjuvant and Salvage Radiotherapy Efficacy and Toxicity
Presenter: Ory Haisraely, M.D.

Abstract 2400: Practice Variations and Outcomes of Definitive Radiation for Non-Metastatic NSCLC following Induction Chemoimmunotherapy
Presenter: Troy Kleber, M.D.

Abstract 2431: Sociodemographic and Molecular Determinants of Disparities in NSCLC Outcomes: A Multi-Institutional Genomic Analysis
Presenter: Cesar Marquez, M.D., Ph.D.

Abstract 2442: Charlson Comorbidity Index as a Predictive Tool of Treatment Tolerance and Outcomes in Elderly Non-Small Cell Lung Cancer Patients Treated with Concurrent Proton or Photon Chemoradiation Followed by Immunotherapy
Presenter: Cira Mollings Puentes, M.D.

Abstract 2446: Association between Geotemporal PM2.5 and Outcomes in Unresectable NSCLC Treated with Chemoradiotherapy
Presenter: Ansel Nalin, M.D., Ph.D.

8:00¨C9:00 a.m.
Hall F

Abstract 2573: Long-Term Outcomes in IDH-Wildtype Gliomas with Historical WHO Grade 2 and 3 Histology
Presenter: Patrick Carriere, M.D., Ph.D.

Abstract 2623: Salvage Fractionated Stereotactic Spine Radiosurgery for Recurrent Metastatic Renal Cell Carcinoma
Presenter: Forrest Kwong, M.D.

Abstract 2651: Outcomes for Patients with High-Risk IDH-Mutant Grade 2 Gliomas Treated with IDH Inhibitors
Presenter: Jane Pearce, M.D.

Abstract 2677: Brain Metastases from Soft Tissue Sarcoma
Presenter: Srivatsa Vedala

10:45 a.m.¨C12:00 p.m.
Hall F

Abstract 2728: Factors Influencing Post-Operative Pain in Gynecologic Cancer Patients Receiving High Dose Rate Brachytherapy: An ERAS Risk Factor Analysis
Presenter: Darien Colson-Fearon, M.D.

Abstract 2745: Severe Sleep-Related Symptoms at Start of Radiotherapy Predict Poorer Survival in Oropharyngeal Cancer: Results from a Longitudinal Symptom Cohort
Presenter: Warren Floyd, M.D., Ph.D.

Abstract 2752: Homologous Recombination Deficiency: Is It Relevant in Locally Advanced Cervical Cancer?
Presenter: Jhoan Sebastian Gonzalez Diaz, M.D.

Abstract 2757: Outcomes of Patients with Gastric-Type Adenocarcinoma of the Uterine Cervix after Definitive or Adjuvant Chemoradiotherapy
Presenter: Harshath Gupta, M.D.

Abstract 2803: A Single Patient-Reported Outcome Item Successfully Detects Imaging-Graded Subclinical Swallow Dysfunction in Patients with Head and Neck Cancer Receiving Radiotherapy
Presenter: Beatrice Manduchi, Ph.D.

Abstract 2810: Management of De-Novo Stage IVB Cervical Cancer with Induction Chemotherapy Followed By Definitive Chemoradiation
Presenter: Cira Mollings Puentes, M.D.

3:00¨C4:00 p.m.
Hall F

Abstract 2964: Cancer Research Training for Oncology Trainees in Zambia: Results from a Hybrid Program's In-Person Workshop
Presenter: Kamaria Lee, M.D.

Abstract 2932: Spatial Protein Profiling of irradiated breast cancer involved lymph nodes suggests nodal irradiation modulates immune function
Presenter: Stephanie Dudzinski, M.D., PhD.

Abstract 2935: To Boost or Not to Boost: Local Control in HER-2 Positive Breast Cancer after Neoadjuvant Therapy
Presenter: Mohamad El-Jammal, M.D.

5:00¨C6:00 p.m.
Hall F

Abstract 3051: Systemic immune activation by SARS-CoV-2 mRNA vaccines sensitizes tumors to immune checkpoint blockade
Presenter: Adam Grippin, M.D., Ph.D.

Abstract 3067: Combining High-Dose Radiation with Dual CCR8 and PD-1 Blockade to Overcome Tumor Immune Suppression
Presenter: Yun Hu, Ph.D.

Abstract 3086: Geographic Distribution of Radiation Oncology Workforce in Underserved Regions: A Cross-Specialty Analysis
Presenter: Forrest Kwong, M.D.

Abstract 3089: Health-Related Social Risks (HRSR) and Psychosocial Needs Among Patients with Breast Cancer Treated with Radiation
Presenter: Kamaria Lee, M.D.

Abstract 3109: The Impact of LET and the Tumor Immune Microenvironment on Differential Response of Genetically Engineered Pancreatic Cancer Models to Carbon Ion Radiotherapy
Presenter: Henry Meyer

Abstract 3116: High Environmental L-Lactate Facilitates DNA Damage Repair Pathway by Inducing Lactylation in Cervical Carcinoma Cells
Presenter: Dalissa Negr¨®n-Figueroa

12:45¨C2:00 p.m.
Hall F

Abstract 3185: Using Deep Learning to Delineate the Elective Pelvic Nodal Volumes in Patients with Prostate Cancer: A Tool Aimed to Facilitate Peer Review
Presenter: Brian Anderson, Ph.D.

Abstract 3186: Clinical Outcomes of Salvage Nodal Radiotherapy for Prostate Cancer with Prior Radiotherapy
Presenter: Maheen Ansari

Abstract 3203: CONSOLIDATE: Concurrent Radiotherapy with Enfortumab vedotin (EV) for Locally Advanced Bladder Cancer
Presenter: Patrick Carriere, M.D., Ph.D.

Abstract 3216: Safety and Early Outcomes of External Beam Radiation Therapy with Low Dose Brachytherapy Boost in Patients with Prostate Cancer
Presenter: Zakaria El Kouzi, M.D.

Abstract 3217: Assessment of Non-Randomized Comparisons of Radical Prostatectomy vs. Radiation Therapy for Prostate Cancer
Presenter: Zakaria El Kouzi, M.D.

Abstract 3243: Changing Landscapes of Adjuvant Radiotherapy after Prostatectomy in Prostate Cancer
Presenter: Harshath Gupta, M.D.

Abstract 3246: Randomized PROSTATE-IQ Trial to Reduce ADT Treatment Burden for Patients with Biochemical Recurrence after Prostatectomy
Presenter: 

Abstract 3372: Investigating Effects of Film Digitization Methods on IROC SRS Head Phantom Credentialing Results
Presenter: Michael Yang

Abstract 3297: Outcomes of Stage IIA and Stage IIB Seminoma Treated with Definitive Radiation Therapy
Presenter: Ansel Nalin, M.D., Ph.D.

Abstract 3298: Cardiovascular Disease and Diagnosis of Advanced Prostate Cancer
Presenter: 

Abstract 3314: Urinary Toxicity after External Beam Radiation Therapy for Prostate Cancer following Transurethral Resection of Prostate or Laser Enucleation
Presenter: Pranalee Patel, M.D.

Abstract 3340: Treatment Outcomes of Radiation Therapy with Androgen Deprivation Therapy in Patients with N1 Prostate Cancer
Presenter: Kayeong Shin, M.D.

2:30¨C3:45 p.m.
Hall F

Abstract 3410: Modest Dose Escalation for Early-Stage Anal Cancer: Cancer Control and Toxicity Outcomes
Presenter: Sage Copling

Abstract 3510: Palliative Radiotherapy within the Last 30 Days of Life: A Multi-Site Review of Practice Patterns
Presenter: Van Handke

Abstract 3392: Phase II Trial of Autologous Lymphocyte Infusions after Radiotherapy to Mitigate Radiation Induced Lymphopenia and Enhance Immune Reconstitution in Patients with Solid Tumor Malignancies
Presenter: Enoch Chang, M.D.

4:00¨C5:00 p.m.
Hall F

Abstract 3591: AI Language Model Performance in Retrieving Phase III Radiotherapy Trials across Mul?ple Cancers
Presenter: Glennon Carevic

Abstract 3602: Outcomes for Patients with Primary Thyroid Lymphoma Treated with Radiation Therapy
Presenter: Ethan Damron, M.D.

Abstract 3623: Development of the Ontology for Osteoradionecrosis of the Jaws (ORNJ-O) for Classification System Harmonization
Presenter: Anthony Giovi

Abstract 3679: Automated Toxicity Extraction from Radiation Therapy Notes Using Large Language Models
Presenter: Jordan McDonald, M.D.

Abstract 3688: A Robust Radiotherapy Continuity System that Enables Patient Treatments during a Cybersecurity Event
Presenter: 

Abstract 3717: Publication Disparity in Hematologic Radiation Oncology
Presenter: Mohamad El-Jammal, M.D.